Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds. Its structure, featuring a piperazine moiety and amine group, supports the development of central nervous system agents, particularly those targeting neurological and psychiatric disorders such as depression, anxiety, or schizophrenia. The compound's stereochemistry (rel-(1R,4R)) and functional groups make it valuable in optimizing drug candidates for improved binding affinity to brain receptors and metabolic stability. The tris(4-methylbenzenesulfonate) (tosylate) salt form enhances stability and water solubility, making it suitable for formulations requiring efficient absorption. It is also employed in structure-activity relationship (SAR) studies to enhance potency and selectivity of new therapeutic molecules.